The radiotherapy treatment comes from an electrical machine called a ‘Linear accelerator’ and is directed as a beam to the part of the body that needs to be treated. Treatment is given daily over a period of days or weeks and you may hear people call these treatments ‘fractions’. They are just a fraction of your treatment dose and plan.
Immunotherapy is a biological therapy and type of targeted treatment that boosts the patient’s natural defence, the immune system, and enables it to find and destroy cancer cells found in the body. At Rutherford Cancer Centres, we use several different types of immunotherapy in the treatment of cancer, in order to prevent cells growing and replicating or spreading around the body.
Chemotherapy at the Rutherford takes place in our modern therapy suites, consisting of up to ten treatment areas offering treatment for haematology/oncology patients requiring systemic anti-cancer therapy (SACT) and supportive care in an outpatient setting. The infusion therapy suites are available for patients undergoing treatment for breast, urology, upper and lower gastrointestinal cancers, and both malignant and non-malignant haematology disorders.
Dr Gaurav Kumar received primary medical education and core oncology training from India. After working as a consultant in oncology in India for many years he attained the Certificate of Equivalence for Specialist Registration (CESR) from the General Medical Council (GMC) in 2015. Since then he has been working as Consultant Clinical Oncologist at The James Cook University Hospital, Middlesbrough. Dr Kumar also has peripheral clinics at North Tees and Hartlepool Hospitals NHS Foundation Trust.
With a special interest in lung and urological cancers including prostate and bladder cancer, he has vast experience in treating these conditions with radiotherapy, chemotherapy and immunotherapy. Besides this he has interests in targeted therapies like Stereotactic Ablative Radiotherapy (SABR/SBRT). With a key interest in clinical trials he has been a part of many national and international trials in both thoracic and urological malignancies. He has been involved in many national and international peer reviewed research article publications from time to time.
General Medical Council – 7504905
Dr Gaurav Kumar does not hold a share or financial interest in the Rutherford Cancer Centres or another Proton Partners International company.
Dr Gaurav Kumar does not have a share or financial interest in equipment used at the Rutherford Cancer Centres or another Proton Partners International company.
Dr Gaurav Kumar does not hold any paid advisory role(s) at the Rutherford Cancer Centres or on behalf of Rutherford Cancer Centres or Proton Partners International.
Get in Touch
If you'd like to speak to us about any of the treatments we offer please don’t hesitate to get in touch. Call us on 0800 210 0402 or